Search - tctmd.com

Displaying 841 - 860 of 3026

Sort: Relevancy | Date

News Daily News

Higher CV Mortality Among More Socially Vulnerable US Adults

Yael L. Maxwell

October 20, 2021

News Daily News

USPSTF at Last Takes Tougher Stance on Aspirin in Primary Prevention

Shelley Wood

October 15, 2021

News Daily News

CAC Tests Boost CAD Prediction in Younger Patients at Risk for ASCVD

Yael L. Maxwell

October 14, 2021

News Daily News

FDA Issues New Guidance on Sodium Targets for Food Industry

L.A. McKeown

October 14, 2021

Antithrombotic therapy does not provide a benefit for clinically stable but symptomatic outpatients with COVID-19, published results of the ACTIV-4b trial affirm. Neither aspirin nor apixaban (Eliquis; Bristol Myers Squibb) at prophylactic or therapeutic doses reduced what were already very low rates of major adverse cardiopulmonary outcomes versus placebo, and both modestly increased bleeding, researchers led by Jean Connors, MD (Brigham and Women’s Hospital, Boston, MA), report in a paper published online

News Daily News

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

Todd Neale

October 13, 2021

News Daily News

HEP-COVID: Therapeutic-Dose Heparin Effective in Non-ICU Patients

Yael L. Maxwell

October 12, 2021

News Daily News

COVID-19: TCTMD’s Dispatch for October Week 2

Todd Neale

October 11, 2021

News Daily News

Diabetes Progression in Statin-Treated Patients: VA Data

Michael O'Riordan

October 06, 2021

News Daily News

Social Determinants of Health Drive Racial CVD Risk Differences

Yael L. Maxwell

October 06, 2021

News Daily News

Post-ACS Patients With Low LDL Levels Remain at Risk: IMPROVE-IT

Michael O'Riordan

October 04, 2021

News Daily News

VALVENOR Study Helps Clarify Risks in Moderate AS Patients

L.A. McKeown

October 01, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2021

Shelley Wood

October 01, 2021

News Daily News

TAVI Is Broadening the Treatable AS Population, Not Cutting Into SAVR

Todd Neale

September 30, 2021

News Daily News

Survey Addresses Cardiac Rehab Challenges and Future Directions

L.A. McKeown

September 27, 2021

News Daily News

Subclinical Atherosclerosis Common in General Population, Even Those With Zero CAC

Yael L. Maxwell

September 24, 2021

News Daily News

In Adults, CV Pathology Dominates COVID-19 Multisystem Inflammatory Syndrome

Shelley Wood

September 23, 2021

News Daily News

AHA Stresses Benefit of Meds, Surgery for Obesity-Related Hypertension

Yael L. Maxwell

September 23, 2021

News Daily News

EXPLANT-TAVR: Data Spur Conversation About Balancing Risk and Lifetime Management

L.A. McKeown

September 22, 2021

News Daily News

Higher Physical Activity Linked With CAC Progression

Yael L. Maxwell

September 21, 2021

News Daily News

Valve-in-Valve TAVI Bests Redo SAVR in Short Term

Michael O'Riordan

September 20, 2021

Advertisement

Higher CV Mortality Among More Socially Vulnerable US Adults

USPSTF at Last Takes Tougher Stance on Aspirin in Primary Prevention

CAC Tests Boost CAD Prediction in Younger Patients at Risk for ASCVD

FDA Issues New Guidance on Sodium Targets for Food Industry

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

HEP-COVID: Therapeutic-Dose Heparin Effective in Non-ICU Patients

COVID-19: TCTMD’s Dispatch for October Week 2

Diabetes Progression in Statin-Treated Patients: VA Data

Social Determinants of Health Drive Racial CVD Risk Differences

Post-ACS Patients With Low LDL Levels Remain at Risk: IMPROVE-IT

VALVENOR Study Helps Clarify Risks in Moderate AS Patients

TCTMD’s Top 10 Most Popular Stories for September 2021

TAVI Is Broadening the Treatable AS Population, Not Cutting Into SAVR

Survey Addresses Cardiac Rehab Challenges and Future Directions

Subclinical Atherosclerosis Common in General Population, Even Those With Zero CAC

In Adults, CV Pathology Dominates COVID-19 Multisystem Inflammatory Syndrome

AHA Stresses Benefit of Meds, Surgery for Obesity-Related Hypertension

EXPLANT-TAVR: Data Spur Conversation About Balancing Risk and Lifetime Management

Higher Physical Activity Linked With CAC Progression

Valve-in-Valve TAVI Bests Redo SAVR in Short Term

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content